CLIENT
Sanofi
Haven Cockerham, Head of Global Allergy
Jordana Barish, Global Sub-Category Head, Allergy
William Ulrick, Head of Content and Creative Excellence
Cecile Angeles , Senior Manager Allergy Portfolio
Vincent Balagat, Sr. Portfolio Lead, Allergy
Danielle Prencipe, Brand Lead
Jennifer Cleary, Commercial Innovation Lead
Richard Qian, Brand Lead
AGENCY
Mark Borcherding, Executive Creative Director
Christine McManus, EVP Client Partner
Bob Friedman, Director, Strategy
Adrienne Haas, Group Account Director
Valerie Perna, Creative Director
Arielle Shorr, ACD/WriterVince Travisano, Executive Creative Director
Laura Bunk, Account Director
Jamison Anthony, ACD/Writer
Adreanna Santos, Art Director
Jon Howarth, Art Director
Erin Scott, Account Executive
Havas Media
Brittany Moten, Director, Connections Planning
Patrick Fraser, VP, Group Director
Cristina Schlobohm, VP, Comms Planning
Ipsos
Havas Media U.S.
SUMMARY
Challenger brand Xyzal outpaces category giants.
With virtually no awareness as a prescription, significantly outspent and a difficult-to-pronounce name, Xyzal needed to disrupt a mature category. Xyzal uncovered an unmet need – the impact of allergies on sleep and next day. Our distinctive campaign featuring our spokes-owl focused on a “smarter way to treat”, changing the treatment paradigm to night. Primary goal - drive brand sales above category. Xyzal sales grew nearly 2x category - 8.4% Xyzal vs. 4.8% - and has outpaced category every month for past 13 months!